IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES, cilt.19, sa.6, ss.685-691, 2016 (SCI-Expanded)
Objective(s): Carbon tetrachloride (CCl4) causes pulmonary toxicity. Infliximab (Ib) is a potent inhibitor of tumor necrosis factor-alpha (TNF-alpha). We aimed to investigate whether Ib has a protective effect on CCl4 induced lung injury.